ZyVersa Therapeutics, Inc.
ZVSA
$0.1221
-$0.0079-6.08%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.29M | -8.84M | -9.41M | -21.33M | -21.83M |
| Total Depreciation and Amortization | -6.10K | -3.50K | -900.00 | -106.60K | 10.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 785.70K | 768.10K | 924.80K | 12.71M | 12.69M |
| Change in Net Operating Assets | 2.35M | 2.52M | 929.90K | -391.90K | -288.40K |
| Cash from Operations | -5.16M | -5.56M | -7.56M | -9.12M | -9.41M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.87M | 5.87M | 6.54M | 8.50M | 10.74M |
| Repurchase of Common Stock | -2.00M | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | 0.00 | -230.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.25M | -735.10K | -588.00K | -833.60K | -1.20M |
| Cash from Financing | 5.12M | 5.13M | 5.95M | 7.67M | 9.31M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 0.00 |
| Net Change in Cash | -47.40K | -422.10K | -1.61M | -1.46M | -109.20K |